Vaxcyte (NASDAQ:PCVX) Given New $100.00 Price Target at The Goldman Sachs Group
Vaxcyte (NASDAQ:PCVX – Free Report) had its price target cut by The Goldman Sachs Group from $138.00 to $100.00 in a report released on Tuesday,Benzinga reports. They currently have a buy rating on the stock. A number of other equities analysts have also recently issued reports on PCVX. Needham & Company LLC cut their target […]
Vaxcyte (NASDAQ:PCVX – Free Report) had its price target cut by The Goldman Sachs Group from $138.00 to $100.00 in a report released on Tuesday,Benzinga reports. They currently have a buy rating on the stock. A number of other equities analysts have also recently issued reports on PCVX. Needham & Company LLC cut their target […]
